Maria Fleseriu MD FACE
Adrenal Disease, Pituitary Disorders & Neuroendocrinology
Professor, Medicine (Endocrinology) and Neurological Surgery, Director Pituitary Center, Oregon Health and Science University
Join to View Full Profile
3303 SW Bond Ave CH8NPortland, OR 97239
Phone+1 503-494-4314
Fax+1 503-346-6810
Dr. Fleseriu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Maria Fleseriu, M.D., F.A.C.E., is an endocrinologist and the director of the OHSU Pituitary Center.
Education & Training
Cleveland Clinic FoundationFellowship, Endocrinology, Diabetes, and Metabolism, 2004 - 2006
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 2002 - 2004
University of Medicine and Pharmacy TimisoaraClass of 1993
Certifications & Licensure
OR State Medical License 2006 - 2027
WA State Medical License 2022 - 2027
OH State Medical License 2002 - 2006
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease Start of enrollment: 2011 Nov 04
- An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. Start of enrollment: 2011 Aug 16
- Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease Start of enrollment: 2014 Mar 06
Publications & Presentations
PubMed
- Approach to the Patient with Cushing's Syndrome: Use of Anticoagulation Therapy.Kristina Isand, John Wass, Niki Karavitaki, Maria Fleseriu, Frederikus A Klok
The Journal of Clinical Endocrinology and Metabolism. 2026-02-20 - Impact of sex on mortality in patients with pituitary adenomas.Elena V Varlamov, Amit Akirov, Monica L Gheorghiu, Maria Fleseriu
Pituitary. 2026-02-06 - Cavernous Sinus Medial Wall Resection: A Retrospective Single-Institution Study on Outcomes in Functional Pituitary Adenomas.Olabisi R Sanusi, Eniola Otukoya, Saud Zaidan, Mathew Geltzeiler, Elena V Varlamov
Operative Neurosurgery. 2026-02-04
Journal Articles
- Changes in Plasma ACTH Levels and Corticotroph Tumor Size in Patients With Cushing's Disease During Long-term Treatment With the Glucocorticoid Receptor Antagonist Mif...Maria Fleseriu,corresponding author James W. Findling, Christian A. Koch, Sven-Martin Schlaffer, Michael Buchfelder, and Coleman Gross, J Clin Endocrinol Metab
- Graves Disease Exacerbation After Pituitary Adenomectomy for Cushing Disease Resulting in an Adrenal CrisisK. Aktas, Mehmet and Fleseriu, Maria and J. Weil, Robert and Faiman, Charles and T. Sergev, Orlin and Reddy, Sethu and Hamrahian, Amir, The Endocrinologist
- Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An UpdateMaria Fleseriu, MD, Endocrine Reviews
Lectures
- New Types of Hypophysitis: Current Knowledge in Diagnosis and Management (Repeat)ENDO 2019 - New Orleans, LA - 3/26/2019
- Guided Posters: Neuroendocrinology and PituitaryENDO 2019 - New Orleans, LA - 3/23/2019
- New Types of Hypophysitis: Current Knowledge in Diagnosis and ManagementENDO 2019 - New Orleans, LA - 3/26/2019
Press Mentions
Redefining Acromegaly Care: First Patient Randomized in Debiopharm’s Phase III OXTEND-03™ Trial of 3-Month Debio 4126 TreatmentDecember 4th, 2025- Behind the Cortisol Trend: Misinformation Could Drive Unnecessary TestingApril 16th, 2025
- A Step-by-Step Guide for Diagnosing Cushing SyndromeAugust 23rd, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
